ACR/ARHP - Preview 2008 - (Page 4) Annenberg Center for Health Sciences:Annenberg Center for Health Sciences 7/23/08 Novel Inhibition of Osteoclast Formation IN OSTEOPOROSIS 4 Join us in San Francisco SUNDAY OCTOBER 26, 2008 6:30 – 8:30 PM daily News Preview ACR/ARHP Annual Scientific Meeting | October 24 – 29, 2008 Implication for Improved Outcomes ARHP keynote continued from page 1 nervous system,” Dr. Bennett said. “When that happens patients seem to have more pain than you would expect objectively, and I think that has been difficult for physicians to understand in the past. What rheumatologists must strive to understand is the complex burden of pain in rheumatology patients, including the psychological aspects that affect pain.” Dr. Bennett will also discuss other causes of chronic pain, including bursitis, tendinitis, myofascial trigger points, and peripheral neuropathies. He will also provide a logical schema for clinicians to use in evaluating chronic pain complaints. “If a patient comes in with osteoarthritis of the knee that is treated effectively, but the patient still complains of pain in the thigh or the leg, how do you evaluate that? I will go through a schema which doctors can use to evaluate each of the potential causes in logical progression, and also how to evaluate development of non-nociceptive pain,” said Dr. Bennett, noting the importance of identifying this type of pain because its treatment is drastically different than treatment for other possible causes. “[Non-nociceptive pain] involves the sort of treatments we would use in fibromyalgia,” he said. During his keynote address, Dr. Bennett will use case presentations to demonstrate the diagnosis of different causes of chronic pain, and then detail management strategies. He will also discuss the principles for treating chronic pain, with a focus on newer and emerging therapies such as antidepressants that affect the descending pathways, cannabinoids, and anti-convulsants such as gabapentin. He’ll also address the use of opioids for pain management. “They are certainly indicated in some patients and we will discuss how to prescribe opioids, some of the problems that doctors have in prescribing them, and how to identify potential abuse,” Dr. Bennett said. Dr. Bennett is a past president of the International Myopain Society and served as president of the former ACR Western Region. In 1995 he founded the Fibromyalgia Information Foundation, which provides the public with information about the history, symptoms, diagnosis, and management of the disease. Along with his colleagues Carol Burckhardt, PhD, and Sharon Clark, PhD, Dr. Bennett developed the Fibromyalgia Impact Questionnaire, now the most widely used instrument in fibromyalgia clinical trials. He has published more than 430 articles and book chapters. Grand Ballroom Intercontinental San Francisco Hotel INTENDED AUDIENCE This activity was developed for rheumatologists and other physicians treating patients with osteoporosis. INTRODUCTION PHOTO: ALFRED PASIEKA / PHOTO RESEARCHERS, INC. The clinical management of osteopenia and osteoporosis by rheumatologists and other physicians is becoming more complex, yet recent and ongoing advances in patient care could result in better rates of fracture prevention and improved outcomes. To accomplish this improvement, there is a need for ongoing education for physicians on a variety of fronts, including the latest fracture risk assessment and intervention algorithm, treatment planning, emerging therapies to prevent and treat osteoporosis, and strategies for improving therapy adherence and long-term treatment outcomes. This activity will address these issues. LEARNING OBJECTIVES SPONSORED BY THE Upon completion of this activity, participants should be better able to: � This activity is supported by an independent educational grant from Amgen Inc. ACCREDITATION Assess the new WHO osteoporosis fracture risk algorithm and its application to the treatment of osteoporosis Discuss factors impacting treatment compliance and persistence, and interventional approaches to improve compliance Distinguish differences in cortical and trabecular bone remodeling and the impact on bone strength and fracture risk reduction Describe the mechanism of action, dosing, safety and efficacy data from the latest clinical studies of current and emerging osteoporosis therapies. Understand the implications of new osteoporosis therapeutic options for patient care. >> For more information, visit www.rheumatology.org. � The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Annenberg Center designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. There is no charge for this activity. Statements of Credit will be mailed 4-6 weeks following activity participation, upon completion and return of the evaluation form to the Annenberg Center for Health Sciences (#4645), 39000 Bob Hope Drive, Rancho Mirage, CA 92270 or by fax to 760-773-4550. DISCLOSURE � � � FACULTY Nancy E. Lane, MD - Moderator University of California at Davis Medical Center Sacramento, California It is the policy of the Annenberg Center to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty participating in sponsored programs are expected to identify and reference off-label product use and disclose any significant relationship with those supporting the activity or any others whose products or services are discussed. Full disclosure will be made in the syllabus. If you need reasonable, special accommodations or have questions about access to any of our activities, please contact Olivia Palmer by phone at 800-321-3690, by fax at 760-773-4550, or by e-mail at registration@annenberg.net. All requests must be received at least 14 days in advance of the intended activity start date. Michael Bolognese, MD Bone Health Center of Bethesda Bethesda, Maryland NEW! Register for the 2008 ACR/ARHP Annual Scientific Meeting and receive complimentary online access to over 90% of the 2008 educational sessions (ticketed and abstract sessions not included) for one full year! This added bonus allows registrants the flexibility to view recorded educational sessions from the 2008 meeting from almost anywhere. Non-attendees will be allowed access to ACR SessionSelect with fees starting at $495. ACR SessionSelect availability begins two weeks after the meeting and will include two viewing options: webcasts and downloadable vodcasts. Bess Dawson-Hughes, MD Tufts University School of Medicine Boston, Massachusetts Stuart Silverman, MD, FACP, FACR Cedars-Sinai UCLA Los Angeles, California ACTIVITY FORMAT This is not an official function /event of the American College of Rheumatology. 6:30 – 7:00 PM 7:00 – 8:30 PM Registration & Dinner Presentations/Q&A FOR MORE INFORMATION, PLEASE CONTACT OLIVIA PALMER AT 800-321- 3690 OR VISIT OUR WEB SITE AT WWW.5STARMEDED.ORG/OSTEO http://WWW.5STARMEDED.ORG/OSTEO http://www.rheumatology.org http://www.rheumatology.org http://WWW.5STARMEDED.ORG/OSTEO
Table of Contents Feed for the Digital Edition of ACR/ARHP - Preview 2008 ACR/ARHP - Preview 2008 ACR/ARHP - Preview 2008 - (Page 1) ACR/ARHP - Preview 2008 - (Page 2) ACR/ARHP - Preview 2008 - (Page 3) ACR/ARHP - Preview 2008 - (Page 4) ACR/ARHP - Preview 2008 - (Page 5) ACR/ARHP - Preview 2008 - (Page 6) ACR/ARHP - Preview 2008 - (Page 7) ACR/ARHP - Preview 2008 - (Page 8)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.